The Journal fur Kardiologie, published by KRAUSE & PACHERNEGG GMBH, is a pivotal resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 1024-0098 and an E-ISSN of 1680-936X, this journal has played a significant role in disseminating valuable research and clinical studies from 1998 until its coverage discontinuation in Scopus in 2017. Despite its Scopus rank being relatively low at #316/324 in its category, it continues to serve as a platform for emerging cardiology research. The journal’s scope encompasses various aspects of cardiovascular health, providing insights that are crucial for researchers, professionals, and students alike seeking to advance their knowledge and practice in cardiology. While the journal is not open access, its contributions to the field are essential for those looking to stay informed about the latest developments in cardiovascular medicine.

JACC: Cardiovascular Interventions is a premier journal dedicated to the field of cardiology and cardiovascular medicine, published by Elsevier Science Inc. This esteemed journal, with an ISSN of 1936-8798 and an E-ISSN of 1876-7605, has established itself as a leading platform for disseminating cutting-edge research and advancements from 2008 to the present, and is projected to continue until 2024. Recognized for its rigorous peer-review process and high-quality content, JACC: Cardiovascular Interventions holds a prestigious Q1 ranking in both Cardiology and Cardiovascular Medicine as well as a Q1 ranking in the broader category of Medicine (Miscellaneous) as of 2023. With a Scopus rank of #25 out of 387 in its field, placing it in the 93rd percentile, the journal is a vital resource for researchers, healthcare professionals, and students alike. Although it does not currently offer open access, its essential contributions to the medical community underscore its importance in advancing cardiovascular intervention knowledge and practice.

TEXAS HEART INSTITUTE JOURNAL, published by the renowned Texas Heart Institute, stands as a pivotal resource in the field of cardiology and cardiovascular medicine. With a history spanning over four decades since its establishment in 1982, this journal addresses a wide range of topics within its scope, including clinical studies, innovative treatments, and groundbreaking research in heart health. Despite its Q3 ranking in both Cardiology and Cardiovascular Medicine, the journal is committed to fostering advancement in medical knowledge and practice, providing an essential platform for healthcare professionals and researchers alike. While currently lacking open access, the journal is recognized for its contributions to the field, aiming to illuminate critical healthcare discussions and promote the exchange of ideas. For those interested in staying at the forefront of cardiovascular research, TEXAS HEART INSTITUTE JOURNAL offers invaluable insights and the latest developments shaping the future of heart care.

The Archives of Cardiovascular Diseases, published by Elsevier Masson, stands as a leading journal in the field of cardiology and cardiovascular medicine, with an impressive impact factor that underscores its relevance and influence. This esteemed journal, recognized in the Q2 category for both cardiology and miscellaneous medicine, aims to disseminate groundbreaking research, innovative methodologies, and clinical advancements that can shape the future of cardiovascular health. With its diverse array of open access options, researchers and students alike have the ability to engage with high-quality content, ensuring that cutting-edge findings are accessible globally. Since its inception in 2008, the journal has actively contributed to the advancement of knowledge in cardiovascular diseases, fostering collaboration among clinicians, researchers, and educators. Headquartered in Paris, France, Archives of Cardiovascular Diseases remains committed to enhancing our understanding of cardiovascular health and improving patient outcomes worldwide.

Circulation-Cardiovascular Interventions, published by LIPPINCOTT WILLIAMS & WILKINS, is a premier journal in the field of cardiology and cardiovascular medicine, recognized for its commitment to advancing the understanding and treatment of cardiovascular diseases. With a robust Impact Factor and ranking in the top 10% of its category, it serves as an essential resource for researchers, clinicians, and students seeking to stay at the forefront of cardiovascular intervention developments. This esteemed journal covers a range of topics, including innovative therapeutic strategies, cutting-edge clinical trials, and comprehensive reviews that inform clinical practice and influence guidelines. Since its inception in 2008, and extending through 2024, Circulation-Cardiovascular Interventions has published pivotal research that shapes the landscape of cardiovascular care in the United States and beyond. Its commitment to high-quality publications makes it an invaluable platform for sharing knowledge and fostering collaboration within the global medical community.

Korean Circulation Journal, published by the Korean Society of Cardiology, has established itself as a prominent platform for disseminating research in the fields of Cardiology and Cardiovascular Medicine. With an ISSN of 1738-5520 and an E-ISSN of 1738-5555, this journal has been at the forefront of cardiovascular science since its inception in 2006 and is projected to continue until 2024. The journal's commitment to quality is reflected in its 2023 category quartiles, ranking in the second quartile (Q2) for both Cardiology and Internal Medicine, as well as its commendable Scopus rankings within the respective fields. Located in South Korea, the journal aims to bridge the gap between cutting-edge research and practical applications, serving as an invaluable resource for researchers, healthcare professionals, and students keen on advancing their understanding of cardiovascular health. Although currently not an open-access journal, it provides a wealth of knowledge that encourages evidence-based practice in clinical settings.

The Journal of Cardiac Surgery, published by Wiley-Hindawi, stands as a pivotal resource in the fields of cardiology, cardiovascular medicine, and surgery, addressing critical developments and innovations in surgical techniques and patient management. Established in 1986, this esteemed journal has cultivated a reputation for nurturing high-quality research, as evidenced by its 2023 Scopus rankings, placing it in the top half for both Medicine: Surgery and Medicine: Cardiology and Cardiovascular Medicine. With an impact factor indicative of its influence in the scientific community, the journal is an essential platform for researchers, medical professionals, and students eager to stay abreast of advancements in cardiac surgery. Readers can access a range of original articles, reviews, and case studies that contribute significantly to our understanding of surgical practices and outcomes. As it converges towards its 2024 milestone, the journal continues to emphasize the importance of innovation in cardiac care, underscoring its commitment to improving patient outcomes worldwide.

Cardiology Journal, published by VIA MEDICA, stands as a prominent resource in the field of cardiology and cardiovascular medicine, with an ISSN of 1897-5593 and an E-ISSN of 1898-018X. Recognized for its Open Access model established since 1994, this journal facilitates widespread dissemination of critical research findings, allowing practitioners and researchers globally to access valuable insights without barriers. Based in Poland, with an address at UL SWIETOKRZYSKA 73, 80-180 GDANSK, it has achieved a respectable Q2 classification in 2023 for both Cardiology and Miscellaneous Medicine categories, reflecting its influence and quality within the scholarly community. With a Scopus ranking placing it at #117 out of 387 in Cardiology, it lies within the 69th percentile, underpinning its commitment to advancing knowledge in cardiovascular health. The journal’s converged years extending from 2006 to 2024 ensure it captures ongoing developments in a rapidly evolving field. As such, the Cardiology Journal serves as an indispensable platform for researchers, professionals, and students dedicated to exploring the frontiers of cardiac science and improving patient care.

SEMINARS IN INTERVENTIONAL RADIOLOGY, published by Thieme Medical Publishers Inc, is a pivotal peer-reviewed journal in the fields of interventional radiology, cardiology, and cardiovascular medicine. With a legacy spanning from 1984 to 2024, this journal serves as an essential resource for professionals seeking to advance their understanding of minimally invasive procedures and imaging techniques. Although it operates under a non-open access model, SEMINARS IN INTERVENTIONAL RADIOLOGY is committed to disseminating high-quality research and clinical insights, thus contributing to ongoing developments in effective medical practices. It enjoys a respectable position within the academic community, indicated by its 2023 rankings of Q3 in both cardiology and radiology categories, reflecting its relevance and influence in the respective fields. This journal not only addresses current trends and challenges but also aims to foster collaboration among researchers and clinicians, emphasizing the importance of evidence-based practices in improving patient outcomes.

Cardiovascular Revascularization Medicine, published by Elsevier Inc, serves as a pivotal platform for research and clinical advancements in the field of cardiology and cardiovascular medicine. With an ISSN of 1553-8389 and an E-ISSN of 1878-0938, this journal has been a key resource since its inception in 2005, converging to highlight innovative approaches for cardiovascular interventions and revascularization techniques through 2024. Although it currently holds a Q3 ranking in both cardiology and general medicine categories as per the 2023 metrics, it continues to empower researchers and healthcare professionals by publishing peer-reviewed articles that bridge the gap between experimental and clinical medicine. With comprehensive coverage of emergent therapies and procedural advancements, Cardiovascular Revascularization Medicine is essential for anyone aiming to stay abreast of the evolving landscape of cardiovascular treatment. Researchers, professionals, and students alike will find invaluable insights and evidence-based research that can impact patient outcomes positively.